SCHEMBL5577696

SCHEMBL5577696

CC(=O)Nc1ccc(C(=O)NCc2ccc(C3CCN(Cc4ccc(N(C)C)cc4)CC3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 4/20 0.54
HDAC1 Q13547 4/20 0.51
TNF P01375 1/20 0.49
NOD2 Q9HC29 1/20 0.49
NOD1 Q9Y239 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
EPHX2 P34913 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HTT P42858 1/20 0.49
KCNH2 Q12809 1/20 0.48
GPR119 Q8TDV5 1/20 0.48
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577876 0.88 ALDH1A1 (0.65) HDAC1MEN1KMT2AKDM4EALDH1A1
SCHEMBL5577864 0.87 ALDH1A1 (0.52) HDAC1MEN1KMT2AKDM4EALDH1A1
SCHEMBL5577280 0.87 MEN1 (0.59) CCR5HDAC1MEN1KMT2AKDM4E
SCHEMBL5577475 0.86 TSHR (0.62) CCR5HDAC1MEN1KMT2AEPHX2
SCHEMBL5577656 0.81 CCR5 (0.53) CCR5NR1H4KDM4EALDH1A1HTT
SCHEMBL5577497 0.81 DRD2 (0.58) CCR5HDAC1MEN1KMT2AKDM4E
SCHEMBL5577622 0.81 MEN1 (0.60) HDAC1MEN1KMT2AALDH1A1KCNH2
SCHEMBL5577563 0.80 DRD2 (0.58) CCR5MEN1KMT2AKCNH2
SCHEMBL5577877 0.79 ALDH1A1 (0.49) HDAC1MEN1KMT2AKDM4EALDH1A1
SCHEMBL5577828 0.79 POLB (0.53) HDAC1MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1616862-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof HLA-DRB1, MIF, HLA-C CCR5 183/4885HDAC1 710/4885TNF 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.